DNA aneuploidy in prostatic adenocarcinoma: a frequent event as shown by fluorescence in situ DNA hybridization.
Fluorescence in situ hybridization (FISH) using specific DNA probes for chromosomes 1, 7, 10, and Y was performed on 53 prostatic tissue samples obtained from 33 radical prostatectomy specimens and two benign control specimens. The 53 samples from carcinomatous prostates included 33 cancerous and 20 noncancerous samples. Additionally, four metastatic lymph node specimens were examined. Clonal chromosome abnormalities were observed in 78% of the tumors studied. They were detected in a higher proportion in stage pT2 and pT3 tumors (86% and 88%, respectively) compared with stage pT1 tumors (25%). No stage pT4 tumor was analyzed. There was evidence of remarkable focal intratumoral heterogeneity documented by the study of two samples from the same tumor in three of six cases. Comparing FISH determined ploidy patterns with DNA flow cytometry (FCM) in 22 samples, FISH showed aneuploidy whereas FCM showed none.
Steilen
H
H
Institute of Human Genetics, University of Saarland, Homburg/Saar, Germany.
Ketter
R
R
Romanakis
K
K
Zwergel
T
T
Unteregger
G
G
Bonkhoff
H
H
Seitz
G
G
Ziegler
M
M
Zang
K D
KD
Wullich
B
B
D000230:Adenocarcinoma / Q000235:genetics* / Q000473:pathology / Q000556:secondary; D000782:Aneuploidy; D004247:DNA / Q000032:analysis*; D005434:Flow Cytometry; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008207:Lymphatic Metastasis / Q000235:genetics* / Q000473:pathology; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology
D004247:DNA